TrialThe Journal of urology2023

Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.

Michael T Schweizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.